![Efficacy and Safety of Once-Daily (QD) Compared with Twice-Daily (BID) Maraviroc plus Optimized Background Therapy (OBT) in treatment-experienced Patients Infected with CCR5-tropic HIV-1: 24-week Combined Analysis of the MOTIVATE 1 & 2 Efficacy and Safety of Once-Daily (QD) Compared with Twice-Daily (BID) Maraviroc plus Optimized Background Therapy (OBT) in treatment-experienced Patients Infected with CCR5-tropic HIV-1: 24-week Combined Analysis of the MOTIVATE 1 & 2](https://www.natap.org/2007/images/073107/events-5.gif)
Efficacy and Safety of Once-Daily (QD) Compared with Twice-Daily (BID) Maraviroc plus Optimized Background Therapy (OBT) in treatment-experienced Patients Infected with CCR5-tropic HIV-1: 24-week Combined Analysis of the MOTIVATE 1 & 2
![Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis | Critical Care | Full Text Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis | Critical Care | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13054-021-03568-8/MediaObjects/13054_2021_3568_Fig2_HTML.png)
Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis | Critical Care | Full Text
![Patient flow diagram. BID, twice daily; PK, pharmacokinetics; QD, once... | Download Scientific Diagram Patient flow diagram. BID, twice daily; PK, pharmacokinetics; QD, once... | Download Scientific Diagram](https://www.researchgate.net/publication/325372028/figure/fig1/AS:630331015172096@1527294033000/Patient-flow-diagram-BID-twice-daily-PK-pharmacokinetics-QD-once-daily.png)
Patient flow diagram. BID, twice daily; PK, pharmacokinetics; QD, once... | Download Scientific Diagram
![Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep31838/MediaObjects/41598_2016_Article_BFsrep31838_Fig1_HTML.jpg)
Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports
![Dosage Calculations The elements of the prescription can be curtailed down to several elements Dose is the amount of drug taken at one time Q is a variable. - ppt video online Dosage Calculations The elements of the prescription can be curtailed down to several elements Dose is the amount of drug taken at one time Q is a variable. - ppt video online](https://slideplayer.com/slide/9379680/28/images/3/Example+Two+i.e.+Timoptic%C2%AE+sig%3A+instill+1+gtt+OU+BID.+Dispense+5+ml+ophthalmic+container.+What+is+the+day+supply.jpg)
Dosage Calculations The elements of the prescription can be curtailed down to several elements Dose is the amount of drug taken at one time Q is a variable. - ppt video online
![Treatment Intensification with Insulin Degludec/Insulin Aspart Twice Daily: Randomized Study to Compare Simple and Step-Wise Titration Algorithms - Endocrine Practice Treatment Intensification with Insulin Degludec/Insulin Aspart Twice Daily: Randomized Study to Compare Simple and Step-Wise Titration Algorithms - Endocrine Practice](https://www.endocrinepractice.org/cms/asset/00e46568-9af4-4d7d-978b-527ec3ca2b3b/fx1.jpg)
Treatment Intensification with Insulin Degludec/Insulin Aspart Twice Daily: Randomized Study to Compare Simple and Step-Wise Titration Algorithms - Endocrine Practice
![PDF] A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. | Semantic Scholar PDF] A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/da636fe1ddd6e8a21289ef039ca3fe546cdc0f89/2-Table2-1.png)
PDF] A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. | Semantic Scholar
![GALACTIC-HF: Omecamtiv mecarbil in patients with heart failure with reduced ejection fraction — NERDCAT GALACTIC-HF: Omecamtiv mecarbil in patients with heart failure with reduced ejection fraction — NERDCAT](https://images.squarespace-cdn.com/content/v1/56a0651bbe7b96af3e170173/1605560030307-YP3S98EPKQ9K83UJUS9C/image-asset.png?format=1000w)
GALACTIC-HF: Omecamtiv mecarbil in patients with heart failure with reduced ejection fraction — NERDCAT
![Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center - Clara Ting, Rhynn Malloy, Danielle Knowles, 2020 Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center - Clara Ting, Rhynn Malloy, Danielle Knowles, 2020](https://journals.sagepub.com/cms/10.1177/1074248420921740/asset/images/large/10.1177_1074248420921740-fig1.jpeg)
Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center - Clara Ting, Rhynn Malloy, Danielle Knowles, 2020
![Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers - John S. Grundy, Christopher D. King, Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers - John S. Grundy, Christopher D. King,](https://journals.sagepub.com/cms/10.1177/2045894020922814/asset/images/large/10.1177_2045894020922814-fig2.jpeg)
Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers - John S. Grundy, Christopher D. King,
Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria | PLOS ONE
![Pharmaceutics | Free Full-Text | Prediction of Drug–Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation Pharmaceutics | Free Full-Text | Prediction of Drug–Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-01489/article_deploy/html/images/pharmaceutics-13-01489-g001.png)
Pharmaceutics | Free Full-Text | Prediction of Drug–Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation
![Safety and Efficacy of Prophylactic Valganciclovir Dosing after Solid Organ Transplant - ATC Abstracts Safety and Efficacy of Prophylactic Valganciclovir Dosing after Solid Organ Transplant - ATC Abstracts](https://atcmeetingabstracts.com/wp-content/uploads/2020/05/g5339_1.png)